{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:15:55Z","timestamp":1791490555173,"version":"4.3.4"},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,7,11]],"date-time":"2003-07-11T00:00:00Z","timestamp":1057881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Pediatr. Oncol."],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cisplatin is not directly toxic to bone, but cisplatin nephrotoxicity leading to magnesium wasting may affect magnesium and calcium metabolism, both of which contribute to bone integrity. The specificity of the magnesium lesion suggests that cisplatin may have an affinity for proteins that regulate magnesium absorption. Sulfhydryls such as amifostine can reduce the toxicity of cisplatin in adults, but current pediatric data do not indicate a role for sulfhydryl therapy to reduce cisplatin toxicity in children. Med Pediatr Oncol 2003;41:186\u2013189, \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/mpo.10335","type":"journal-article","created":{"date-parts":[[2003,7,14]],"date-time":"2003-07-14T10:09:16Z","timestamp":1058177356000},"page":"186-189","source":"Crossref","is-referenced-by-count":44,"title":["Cisplatin nephrotoxicity affects magnesium and calcium metabolism"],"prefix":"10.1002","volume":"41","author":[{"given":"Marshall P.","family":"Goren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.1999.0097"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(85)90127-0"},{"key":"e_1_2_1_4_2","first-page":"1767","article-title":"Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer","volume":"66","author":"Schilsky RL","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01613129"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83372-4"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00857658"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000168288"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050507"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(84)90086-6"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007260170060"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.6.1441"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199902)32:2<93::AID-MPO4>3.0.CO;2-Y"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.140.11.1513"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-29-6-842"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-42-4-707"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-113-6-2294"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.51"},{"key":"e_1_2_1_20_2","first-page":"375","article-title":"Cis\u2010platinum and distal renal tubule toxicity","volume":"98","author":"Swainson CP","year":"1985","journal-title":"New Zealand Med J"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.217"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183834"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.239"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.117287"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114599001130"},{"key":"e_1_2_1_26_2","first-page":"257","article-title":"Magnesium deficiency\u2010induced osteoporosis in the rat: Uncoupling of bone formation and bone resorption","volume":"12","author":"Rude RK","year":"1999","journal-title":"Magnes Res"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/jn\/130.2.216","article-title":"Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats","volume":"130","author":"Toba Y","year":"2000","journal-title":"J Nutr"},{"key":"e_1_2_1_28_2","first-page":"249","article-title":"Long\u2010term excessive magnesium supplementation is deleterious whereas suboptimal supply is beneficial for bones in rats","volume":"13","author":"Riond JL","year":"2000","journal-title":"Magnes Res"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.8"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr980421n"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.2.183"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1992.tb00445.x"},{"key":"e_1_2_1_33_2","first-page":"35","article-title":"Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: Possible role in nephrotoxicity","volume":"61","author":"Litterst CL","year":"1988","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0750203"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100610"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1124\/mol.59.4.837","article-title":"Modulation of cisplatin cytotoxicity and cisplatin\u2010induced DNA cross\u2010links in HepG2 cells by regulation of glutathione\u2010related mechanisms","volume":"59","author":"Zhang K","year":"2001","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3333"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.04.178"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006490226104"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200203000-00006"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-911X(20010101)36:1<199::AID-MPO1048>3.0.CO;2-0"},{"key":"e_1_2_1_42_2","first-page":"4531","article-title":"Effect of amifostine on neuroblastoma during high dose chemotherapy: In vivo and in vitro investigations","volume":"20","author":"Renner S","year":"2000","journal-title":"Anticancer Res"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010815)92:4<914::AID-CNCR1401>3.0.CO;2-S"}],"container-title":["Medical and Pediatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpo.10335","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.10335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T02:20:36Z","timestamp":1700274036000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.10335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1002\/mpo.10335"],"URL":"https:\/\/doi.org\/10.1002\/mpo.10335","archive":["Portico"],"relation":{},"ISSN":["0098-1532","1096-911X"],"issn-type":[{"value":"0098-1532","type":"print"},{"value":"1096-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,11]]}}}